Manuel C. Cabezas

Zeist, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Feasibility and Effects of a Produce Prescription Program (PRx) in People With Type 2 Diabetes and Low Socioeconomic Status: A Randomised Controlled Pilot Trial.

Feasibility and Effects of a Produce Prescription Program (PRx) in People With Type 2 Diabetes and Low Socioeconomic Status: A Randomised Controlled Pilot Trial.

Journal: Diabetes, obesity & metabolism

Published: May 20, 2026

LAP-defined hepatic steatosis and cardiometabolic risk in rheumatoid arthritis: a post-hoc analysis of the FRANCIS randomized trial.

LAP-defined hepatic steatosis and cardiometabolic risk in rheumatoid arthritis: a post-hoc analysis of the FRANCIS randomized trial.

Journal: Rheumatology international

Published: May 19, 2026

Validated Early Detection Metrics Reduce the Population Requiring Liver Fibrosis Screening.

Validated Early Detection Metrics Reduce the Population Requiring Liver Fibrosis Screening.

Journal: Gastroenterology

Published: March 09, 2026

Differences in Diagnosing Tarsal Tunnel Syndrome Across the Literature: A Systematic Review and a Call for Standardization.

Differences in Diagnosing Tarsal Tunnel Syndrome Across the Literature: A Systematic Review and a Call for Standardization.

Journal: JBJS reviews

Published: February 09, 2026

Effect of bempedoic acid on cardiovascular risk in patients with metabolic dysfunction-associated steatotic liver disease.

Effect of bempedoic acid on cardiovascular risk in patients with metabolic dysfunction-associated steatotic liver disease.

Journal: European journal of preventive cardiology

Published: October 05, 2025

Reply to: "Statins in MASLD: Challenges and future directions".

Reply to: "Statins in MASLD: Challenges and future directions".

Journal: JHEP reports : innovation in hepatology

Published: April 09, 2025

Effects of Mediterranean diet, exercise, and their combination on body composition and liver outcomes in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis of randomized controlled trials.

Effects of Mediterranean diet, exercise, and their combination on body composition and liver outcomes in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis of randomized controlled trials.

Journal: BMC medicine

Published: February 18, 2025

Steatotic Liver Disease as a Risk Enhancer in the Presence of Metabolic Syndrome.

Steatotic Liver Disease as a Risk Enhancer in the Presence of Metabolic Syndrome.

Journal: European journal of preventive cardiology

Published: February 02, 2025

Pharmacological treatment options for metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus: A systematic review.

Pharmacological treatment options for metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus: A systematic review.

Journal: European journal of clinical investigation

Published: November 07, 2024

Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk factors in rheumatoid arthritis.

Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk factors in rheumatoid arthritis.

Journal: Clinical rheumatology

Published: October 31, 2024

Normalization of Cardiac Function After Bariatric Surgery Is Related to Autonomic Function and Vitamin D.

Normalization of Cardiac Function After Bariatric Surgery Is Related to Autonomic Function and Vitamin D.

Journal: Obesity surgery

Published: July 29, 2022

Biomarker profiles in obesity patients and their relation to cardiac dysfunction.

Biomarker profiles in obesity patients and their relation to cardiac dysfunction.

Journal: Biomarkers in medicine

Published: September 09, 2021

Showing 1-12 of 24

Last Updated: 09/26/2026